Wealth Architects, LLC Abb Vie Inc. Transaction History

Wealth Architects, LLC

$739 Million
Q1 2024

A detailed history of Wealth Architects, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Wealth Architects, LLC holds 4,885 shares of ABBV stock, worth $817,016. This represents 0.12% of its overall portfolio holdings.

Number of Shares

4,885

Previous 4,641 5.26%

Holding current value

$817,016

Previous $719,000 23.64%

% of portfolio

0.12%

Previous 0.1%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$159.82 - $182.1 $38,996 - $44,432	244 Added 5.26%	4,885 $889,000
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $28,070 - $31,613	-204 Reduced 4.21%	4,641 $719,000
Q3 2023 Nov 09, 2023	BUY	$133.59 - $154.65 $9,484 - $10,980	71 Added 1.49%	4,845 $722,000
Q2 2023 Aug 02, 2023	BUY	$132.51 - $164.9 $4,240 - $5,276	32 Added 0.67%	4,774 $643,000
Q1 2023 Apr 21, 2023	SELL	$144.61 - $166.54 $35,429 - $40,802	-245 Reduced 4.91%	4,742 $755,000

Q4 2022 Feb 09, 2023	BUY	$138.31 - $165.87 $2,627 - $3,151	19 Added 0.38%	4,987 $806,000
Q3 2022 Oct 24, 2022	BUY	$134.21 - $153.93 $52,476 - $60,186	391 Added 8.54%	4,968 $667,000
Q2 2022 Jul 29, 2022	BUY	$137.62 - $174.96 $9,082 - $11,547	66 Added 1.46%	4,577 $701,000
Q1 2022 May 17, 2022	BUY	$131.98 - $163.75 $8,842 - $10,971	67 Added 1.51%	4,511 $731,000
Q4 2021 Jan 19, 2022	BUY	$107.43 - $135.93 $39,211 - $49,614	365 Added 8.95%	4,444 $602,000
Q3 2021 Nov 09, 2021	BUY	$106.4 - $120.78 $10,427 - $11,836	98 Added 2.46%	4,079 $440,000
Q2 2021 Aug 09, 2021	BUY	$105.21 - $117.21 $4,524 - $5,040	43 Added 1.09%	3,981 $448,000
Q1 2021 Apr 29, 2021	BUY	$102.3 - $112.62 $4,501 - $4,955	44 Added 1.13%	3,938 $426,000
Q4 2020 Jan 28, 2021	SELL	$80.49 - $108.67 $2,817 - $3,803	-35 Reduced 0.89%	3,894 $417,000
Q3 2020 Nov 09, 2020	BUY	$85.91 - $100.83 $43,126 - $50,616	502 Added 14.65%	3,929 $344,000
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $16,068 - $21,501	219 Added 6.83%	3,427 $336,000
Q1 2020 Apr 23, 2020	BUY	$64.5 - $97.79 $10,707 - $16,233	166 Added 5.46%	3,208 $244,000
Q4 2019 Jan 28, 2020	BUY	$72.13 - $90.25 $12,189 - $15,252	169 Added 5.88%	3,042 $269,000
Q3 2019 Oct 23, 2019	BUY	$62.98 - $75.72 $180,941 - $217,543	2,873 New	2,873 $218,000
Q2 2019 Jul 12, 2019	SELL	$65.7 - $83.98 $208,860 - $266,972	-3,179 Closed	0 $0
Q1 2019 May 01, 2019	SELL	$77.14 - $90.79 $123,809 - $145,717	-1,605 Reduced 33.55%	3,179 $256,000
Q4 2018 Jan 17, 2019	SELL	$77.85 - $96.01 $32,463 - $40,036	-417 Reduced 8.02%	4,784 $441,000
Q3 2018 Oct 04, 2018	BUY	$88.91 - $98.84 $76,106 - $84,607	856 Added 19.7%	5,201 $492,000
Q2 2018 Jul 19, 2018	BUY	$89.78 - $106.23 $7,451 - $8,817	83 Added 1.95%	4,345 $403,000
Q1 2018 Apr 13, 2018	SELL	$92.01 - $123.21 $189,632 - $253,935	-2,061 Reduced 32.6%	4,262 $403,000
Q4 2017 Jan 31, 2018	SELL	$89.56 - $98.21 $14,150 - $15,517	-158 Reduced 2.44%	6,323 $611,000
Q3 2017 Nov 08, 2017	SELL	$69.85 - $89.22 $133,832 - $170,945	-1,916 Reduced 22.82%	6,481 $576,000
Q2 2017 Aug 10, 2017	BUY	N/A	8,397	8,397 $608,000

Others Institutions Holding ABBV

# of Institutions

3,653

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $296B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Architects, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Architects, LLC with notifications on news.

Account

Wealth Architects, LLC Abb Vie Inc. Transaction History